CIK 0001782223 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Pyxis Oncology, Inc.
Sign in to watch- Ticker
- PYXS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831160910
- Phone
- (617) 221-9059
- Business address
- 321 HARRISON AVENUE, BOSTON, MA, 02118
- Open-market buys, last 90 days
- $0
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 4 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-17 | PFIZER INC 10% owner | Purchase | +1,811,594 | $2.76 | $5.0M | 5,952,263 |
| 2023-01-03 | Sullivan Lara Chief Executive Officer | Grant or award | +95,684 | 1,452,320 | ||
| 2023-01-03 | Feingold Jay Chief Medical Officer | Grant or award | +53,931 | 520,542 | ||
| 2023-01-03 | Yanchik Connealy Pamela Chief Financial Officer | Grant or award | +43,493 | 384,510 | ||
| 2022-08-11 | HUMPHREY RACHEL Director | Grant or award · Stock Option (Right to Buy) | +236,220 | 236,220 | ||
| 2022-04-21 | Chin Mark Former Director | Sale | −1,745,761 | $3.05 | $5.3M | 0 |
| 2022-04-14 | Yanchik Connealy Pamela Chief Financial Officer | Grant or award | +93,493 | 341,017 | ||
| 2022-04-14 | Feingold Jay Chief Medical Officer | Grant or award | +115,931 | 466,611 | ||
| 2022-04-14 | Sullivan Lara Chief Executive Officer | Grant or award | +315,273 | 1,356,636 | ||
| 2022-03-31 | Sullivan Lara Chief Executive Officer | Grant or award | +742,574 | 1,041,363 | ||
| 2022-03-31 | FLAVIN JOHN L Director | Grant or award | +66,831 | 238,441 | ||
| 2022-03-31 | Civik Thomas Director | Grant or award | +66,831 | 66,831 | ||
| 2022-03-31 | Feingold Jay Chief Medical Officer | Grant or award | +306,930 | 350,680 | ||
| 2022-03-31 | Chin Mark Director | Grant or award | +66,831 | 66,831 | ||
| 2022-03-31 | Yanchik Connealy Pamela Chief Financial Officer | Grant or award | +247,524 | 247,524 | ||
| 2022-03-31 | Cline Darren S Director | Grant or award | +66,831 | 76,831 | ||
| 2022-03-31 | Lewis-Hall Freda C Director | Grant or award | +66,831 | 66,831 | ||
| 2021-12-08 | Cline Darren S Director | Purchase | +10,000 | $9.39 | $94K | 10,000 |
| 2021-12-06 | Yanchik Connealy Pamela Chief Financial Officer | Grant or award · Stock Option (Right to buy) | +52,944 | 52,944 | ||
| 2021-11-18 | Civik Thomas Director | Purchase | +15,700 | $12.74 | $200K | 15,700 |
Page 6 of 7 · 137 trades